- Report
- December 2021
Global
From €31581EUR$34,500USD£26,841GBP
- Report
- August 2021
- 1730 Pages
Asia Pacific
From €13273EUR$14,500USD£11,281GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1373EUR$1,500USD£1,167GBP
- Report
- October 2022
- 300 Pages
Global
From €2364EUR$2,583USD£2,010GBP
€3378EUR$3,690USD£2,871GBP
- Report
- April 2022
- 210 Pages
Global
From €2215EUR$2,419USD£1,882GBP
€3164EUR$3,456USD£2,689GBP
- Report
- April 2022
- 180 Pages
Global
From €2284EUR$2,496USD£1,941GBP
€3263EUR$3,565USD£2,774GBP
- Book
- July 2015
- 328 Pages
- Book
- April 2022
- 288 Pages
- Book
- February 2019
- 480 Pages
- Book
- July 2018
- 320 Pages
- Book
- April 2015
- 352 Pages
- Book
- February 2010
- 340 Pages
Global
- Book
- April 2024
Australia

Pneumonia is an infectious disease caused by bacteria, viruses, or fungi that affects the lungs. It is one of the most common infectious diseases and is a leading cause of death worldwide. Infectious disease testing is used to diagnose and monitor the progression of pneumonia. Tests used to diagnose pneumonia include chest X-rays, sputum cultures, and blood tests. Treatment for pneumonia typically involves antibiotics, antivirals, and other medications.
The pneumonia market within the context of infectious disease testing is a rapidly growing market. It is driven by the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis. The market is expected to grow due to the increasing prevalence of pneumonia, the development of new diagnostic technologies, and the increasing demand for rapid and accurate diagnosis.
Some companies in the pneumonia market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more